Lachica, Adela .
HRN: 23-15-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/14/2023
06/21/2023
IV
4.5g
Q8
Cellulitis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes